RLMD logo
RLMD NASDAQ US

Relmada Therapeutics, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Mar 2014
$6.99
▼ $-0.11 (-1.55%)
Vol 1.8M
3
Quality Score
fail
Mkt Cap
$354.2M
ROE
-269.5%
D/E
0.00
Beta
0.78
52W
$0–$5

Wall Street Consensus

11 analysts · Apr 2026
4
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
90.9%
Buy Rating

Price Chart

Similar Stocks

PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
OMER
Omeros Corp
$1.2B
SGP
SpyGlass Pharma Inc
ARVN
Arvinas Inc
$761.7M
ETON
Eton Pharmaceuticals Inc
$453.5M
LXRX
Lexicon Pharmaceuticals Inc
$417.9M
ESPR
Esperion Therapeutics Inc
$884.5M
LBRX
LB Pharmaceuticals Inc
$563.2M

Earnings

Beat rate: 20.0%
Next Report May 11, 2026
EPS Estimate: $-0.20
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.20 — —
Dec 2025 $-0.14 $-0.29 $-0.15
Sep 2025 $-0.12 $-0.30 $-0.18
Jun 2025 $-0.26 $-0.30 $-0.05

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -223.4% -225.8% -223.4% -223.4% -223.4% -269.5%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 4.11 4.09 4.11 4.11 4.11 2.86

Key Ratios

ROA (TTM)
-205.2%
P/B
0.4
EPS (TTM)
$-1.80
CF/Share
$-3.71
52W High
$5.12
52W Low
$0.24
$0.24 52-Week Range $5.12

How does RLMD compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

RLMD AARD ACB ACRS ADIL

RLMD valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.4
▼ 79% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

RLMD profitability vs Pharmaceuticals peers

ROE
-269.5%
▼ 397% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-205.2%
▼ 448% below peers (-37.4%)
vs Peers
vs Industry
Weak

RLMD financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
2.9
▼ 15% below peers (3.4)
vs Peers
vs Industry
In line
Beta
0.8
▼ 17% below peers (0.9)
vs Peers
vs Industry
More volatile

RLMD fundamentals radar

RLMD Peer median Industry

RLMD profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

RLMD vs peers: key metrics

Latest News

No related news yet